Locations inspection manufacturers

drugs

Conducting GMP audits in order to
prepare for the upcoming inspection
by the national inspectorate... More

 

The geography of our audits covers

Russia and CIS countries

Western and Eastern Europe,
countries of Southeast Asia and
the Middle East, India, Japan

GMP News

31 Jan
Oncologist talked about nicotine-containing foods

     Many smokers are amazed when they find out that they get nicotine not only by smoking, but also by using products usual and familiar from childhood, said Dmitry Strunkin, chief physician and head of the Cancer Consultation Center “Anticancer Center” (Novosibirsk).

24 Jan
Federal Service for Supervision in Healthcare did not agree with the conclusions of Russian Quality System about the masks low protection properties against viruses.

     Roszdravnadzor (Federal Service for Supervision in Healthcare) believes that the conclusions of Roskachestvo (Russian Quality System) that masks provide little protection against viruses cannot be considered reliable, since in Russia there is no requirement and method for testing the virus permeability for medical masks.

 

13 Dec
Omicron-strain of coronavirus detected in 16 Russians returning from South Africa

     “Out of 177 citizens who returned today, 16 were found to have the omicron strain, they are all under observation,” Golikova said during a speech in the State Duma.

24 Nov
In October, the activity of pharmaceutical companies in digital communications with doctors increased.

     The share of corporate digital contacts with doctors in the overall structure of multichannel promotion increased in October, while the share of digital in the structure of personal communications of medical representatives did not change.

09 Nov
Registration is now open for a webinar on antibiotics for treating bacterial pneumonia in COVID-19

     A webinar on the topic "Antibiotics for bacterial-viral pneumonia and their combinations with other classes of drugs" will be held on the website www.katrenstyle.ru on November 16, Tuesday, at 12:00 Moscow time.

08 Sep
Scientists have announced the risk of side effects with a massive revaccination from COVID-19

     A team of scientists, which included staff from the WHO, the FDA and the world's leading universities, conducted a study that showed the emergence of side effects due to revaccination. Patients who give booster doses too early or too often may develop myocarditis or Guillain-Barré syndrome.

Subscribe

Feedback

 
 

8-495-004-50-76

105064, Moscow, Nizhny Susalny lane, 5, p.19 room XI, room.2

info@gmp-project.ru

Sitemap

"GMP-Project" - a company that specializes in assisting in the preparation of the inspection of manufacturers of medicinal products for compliance with the rules of good manufacturing practice, the activity of which is located outside the Russian Federation.